Evaluation of Potencies of Immune Globulin Products Against Hepatitis A

JAMA Intern Med. 2017 Mar 1;177(3):430-432. doi: 10.1001/jamainternmed.2016.9057.

Authors

Alexandra Tejada-Strop¹, Maria Isabel Costafreda², Zoya Dimitrova¹, Gerardo G Kaplan², Chong-Gee Teo¹

Affiliations

¹ Division of Viral Hepatitis, Centers for Disease Control and Prevention, Atlanta, Georgia.
² Office of Blood Research and Review, Center for Biologics Evaluation and Research, Food and Drug Administration, Silver Spring, Maryland.

PMID: 28097299
DOI: 10.1001/jamainternmed.2016.9057

No abstract available

Publication types

Letter
Research Support, U.S. Gov't, P.H.S.

MeSH terms

Drug Evaluation / methods*
Hepatitis A / prevention & control*
Humans
Immunoglobulin G / administration & dosage*
Immunologic Factors / administration & dosage
Injections, Intramuscular

Substances

Immunoglobulin G
Immunologic Factors